XL-647 Size:Solid 10 mg Molecular Weight: 418

Molecular Weight: 418

glutamate-cysteine ligase catalytic subunit (Gclc) and glutamate-cysteine ligase regulatory subunit (Gclm)

Administration of (R)-MG-132 effectively rescues the expression levels and plasma membrane localization of dystrophin

8-tetraenoic acid

XL-647 Size:Solid 10 mg Molecular Weight: 418Tesevatinib, also known as XL647, EXEL 7647 and KD 019, is a n orally bioavailable small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. XL647 binds to and inhibits several tyrosine receptor kinases that play major roles in tumor cell proliferation and tumor vascularization, including epidermal growth factor receptor (EGFR; ERBB1), epidermal growth factor receptor 2 (HER2; ERBB2), vascular endothelial growth